CIPLA
Back to All Ratios
|
CIPLA Last 5 Year Pre Tax Margin History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Pre Tax Margin(%) | 13.05 | 11.75 | 11.66 | 8.03 | 8.70 |
What is the latest Pre Tax Margin ratio of CIPLA ?
Year | Pre Tax Margin |
---|---|
Mar2023 | 13.05 |
Mar2022 | 11.75 |
Mar2021 | 11.66 |
Mar2020 | 8.03 |
Mar2019 | 8.70 |
How is Pre Tax Margin of CIPLA Trending?
Years | Pre Tax Margin | % Change | |
---|---|---|---|
Mar2023 | 13.05 | 11.06 | |
Mar2022 | 11.75 | 0.77 | |
Mar2021 | 11.66 | 45.21 | |
Mar2020 | 8.03 | -7.70 | |
Mar2019 | 8.7 | - |
Other Financial Ratios of CIPLA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Pre Tax Margin ratio of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹116,923.6 Cr | -2% | 2% | 53.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹350,339.0 Cr | -0.5% | -3.8% | 50.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹114,416.0 Cr | 1.3% | 8.7% | 26.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,694.0 Cr | -5.5% | 1.3% | 99.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,546.9 Cr | -1.7% | -8% | 28.9% | Stock Analytics | |
MANKIND PHARMA | ₹85,978.3 Cr | 1.5% | -8.1% | 53.1% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -2% |
2% |
53.3% |
SENSEX | -1.9% |
-0.7% |
18.3% |
You may also like the below Video Courses